Utility of Covariate-Adjusted Response-Adaptive Randomization in Survival Trials

Statistics in Biopharmaceutical Research

Volumn 5, Issue 1, 2013, Pages 38-53

  Sverdlov, Oleksandr ^a   Rosenberger, William F ^b   Ryeznik, Yevgen ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b George Mason University   (United States)

^c CS Ltd   (Ukraine)

Author keywords

Adaptive design; Censoring; Efficiency; Ethical concern; Power; Unequal allocation

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; K RAS PROTEIN; PACLITAXEL;

ARTICLE; COLORECTAL CANCER; COVARIATE ADJUSTED RESPONSE ADAPTIVE DESIGN; DRUG EFFICACY; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; METHODOLOGY; OVERALL SURVIVAL; PATIENT SELECTION; PROGRESSION FREE SURVIVAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS; SIMULATION; SURVIVAL;

EID: 84874293737     PISSN: None     EISSN: 19466315     Source Type: Journal    
DOI: 10.1080/19466315.2012.754376     Document Type: Article

References (28)

1. Atkinson, A. C. 1982. "Optimum Biased Coin Designs for Sequential Clinical Trials With Prognostic Factors,". Biometrika, 69: 61-67.
2. Atkinson, A. C. and Biswas, A. 2005. "Bayesian Adaptive Biased-Coin Designs for Clinical Trials With Normal Responses,". Biometrics, 61: 118-125.
3. Baldi Antognini, A. and Zagoraiou, M. 2010. "Covariate Adjusted Designs for Combining Efficiency, Ethics and Randomness in Normal Response Trials,". In mODa 9-Advances in Model-Oriented Design and Analysis, Edited by: Giovagnoli, A., Atkinson, A. C., Torsney, B. and May, C. 17-24. Heidelberg: Physica-Verlag.
4. Bandyopadhyay, U., Biswas, A. and Bhattacharya, R. 2010. "A Covariate-Adjusted Adaptive Design for Two-Stage Clinical Trials With Survival Data,". Statistica Neerlandica, 64: 202-226.
5. Behrendt, C. E. and Gehan, E. A. 2009. "Treatment-Subgroup Interaction: An Example From a Published, Phase II Clinical Trial,". Contemporary Clinical Trials, 30: 279-281.
6. Biswas, A. and Angers, J. F. 2002. "A Bayesian Adaptive Design in Clinical Trials for Continuous Responses,". Statistica Neerlandica, 56: 400-414.
7. Chappell, R. and Karrison, T. 2006. Letter to the Editor,. Statistics in Medicine, 26: 3050-3052.
8. Cheung, Y. K., Lurdes, Y. T., Wathen, J. K. and Thall, P. F. 2006. "Continuous Bayesian Adaptive Randomization Based on Event Times With Covariates,". Statistics in Medicine, 25: 55-70.
9. Hu, F. and Rosenberger, W. F. 2003. "Optimality, Variability, Power: Evaluating Response-Adaptive Randomization Procedures for Treatment Comparisons,". Journal of the American Statistical Association, 98: 671-678.
10. Hu, F. and Rosenberger, W. F. 2006. The Theory of Response-Adaptive Randomization in Clinical Trials, New York: Wiley.
11. Hu, F. and Zhang, L. X. 2004. "Asymptotic Properties of Doubly Adaptive Biased Coin Designs for Multitreatment Clinical Trials,". The Annals of Statistics, 32: 268-301.
12. Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., Price, T. J., Shepherd, L., Au, H-J, Langer, C., Moore, M. J. and Zalchberg, J. R. 2008. "K-ras Mutations and Benefit From Cetuximab in Advanced Colorectal Cancer,". The New England Journal of Medicine, 359: 1757-1765.
13. Latta, R. B. 1981. "A Monte Carlo Simulation of Some Two-Sample Rank Tests With Censored Data,". Journal of the American Statistical Association, 76: 713-719.
14. Lawless, J. 2003. Statistical Models and Methods for Lifetime Data, New York: Wiley.
15. Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., Nishiwaki, Y., Ohe, Y., Yang, J.-J., Chewaskulyong, B., Jiang, H., Duffield, E. L., Watkins, C. L., Armour, A. A. and Fukuoka, M. 2009. "Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma,". The New England Journal of Medicine, 361: 947-957.
16. Pocock, S. J. and Simon, R. 1975. "Sequential Treatment Assignment With Balancing for Prognostic Factors in the Controlled Clinical Trial,". Biometrics, 31: 103-115.
17. Rosenberger, W. F. and Hu, F. 2004. "Maximizing Power and Minimizing Treatment Failures in Clinical Trials,". Clinical Trials, 1: 141-147.
18. Rosenberger, W. F. and Seshaiyer, P. 1997. "Adaptive Survival Trials,". Journal of Biopharmaceutical Statistics, 7: 617-624.
19. Rosenberger, W. F. and Sverdlov, O. 2008. "Handling Covariates in the Design of Clinical Trials,". Statistical Science, 23: 404-419.
20. Rosenberger, W. F., Vidyashankar, A. N. and Agarwal, D. K. 2001. "Covariate-Adjusted Response-Adaptive Designs for Binary Response,". Journal of Biopharmaceutical Statistics, 11: 227-236.
21. Smith, R. L. 1984. "Sequential Treatment Allocation Using Biased Coin Designs,". Journal of the Royal Statistical Society, Series B, 46: 519-543.
22. Sverdlov, O., Tymofyeyev, Y. and Wong, W. K. 2011. "Optimal Response-Adaptive Randomized Designs for Multi-Armed Survival Trials,". Statistics in Medicine, 30: 2890-2910.
23. Taves, D. R. 1974. "Minimization: A New Method of Assigning Patients to Treatment and Control Groups,". Clinical Pharmacology and Therapeutics, 15: 443-453.
24. Yuan, Y., Huang, X. and Liu, S. 2011. "A Bayesian Response-Adaptive Covariate-Balanced Randomization Design With Application to a Leukemia Clinical Trial,". Statistics in Medicine, 30: 1218-1229.
25. Zhang, L-X and Hu, F. 2009. "A New Family of Covariate-Adjusted Response-Adaptive Designs and Their Properties,". Applied Mathematics-A Journal of Chinese Universities, 24: 1-13.
26. Zhang, L.-X., Hu, F., Cheung, S. H. and Chan, W. S. 2007. "Asymptotic Properties of Covariate-Adjusted Response-Adaptive Designs,". The Annals of Statistics, 35: 1166-1182.
27. Zhang, L. and Rosenberger, W. F. 2007. "Response-Adaptive Randomization for Survival Trials: The Parametric Approach,". Applied Statistics, 56: 153-165.
28. Zhu, H. and Hu, F. 2010. "Covariate-Adjusted Response Adaptive Randomization Design With Survival Responses,". Presented at 2010 Joint Statistical Meetings, Vancouver, Canada,